Examination of adhesion molecules, homocysteine and hs-CRP in patients with polygenic hypercholesterolemia and isolated hypertriglyceridemia

Internal Medicine

Volumn 50, Issue 15, 2011, Pages 1529-1535

  Calan, Mehmet ^a   Calan, Ozlem ^a   Gonen, Mustafa Sait ^b   Bilgir, Ferda ^c   Kebapcilar, Levent ^b   Kulac, Esin ^d   Cinali, Turker ^c   Bilgir, Oktay ^c  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

^c Izmir Bozyaka Training and Research Hospital   (Turkey)

^d SULEYMAN DEMIREL UNIVERSITY   (Turkey)

Author keywords

Adhesion molecules; Ho mocysteine; Hs CRP; Isolated hypertriglyceridemia; Polygenic hypercholesterolemia; Selectins

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PADGEM PROTEIN; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BODY MASS; C REACTIVE PROTEIN BLOOD LEVEL; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; E SELECTIN BLOOD LEVEL; FEMALE; HOMOCYSTEINE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INTERCELLULAR ADHESION MOLECULE 1 BLOOD LEVEL; MALE; P SELECTIN BLOOD LEVEL; POLYGENIC HYPERCHOLESTEROLEMIA; PROTEIN BLOOD LEVEL; VASCULAR CELL ADHESION MOLECULE 1 BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; E-SELECTIN; FEMALE; HOMOCYSTEINE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; HYPERTRIGLYCERIDEMIA; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; MULTIFACTORIAL INHERITANCE; P-SELECTIN; RISK FACTORS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 79961204492     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.4297     Document Type: Article

References (36)

1. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apostpran-dialarently healthy men. Lancet 351: 88-92, 1998.
2. Hwang S-J, Ballantyne CM, Sharret AR, et al. Circulating adhesion molecules VCAM-1 ICAM-1 and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 96: 4219-4225, 1997.
3. Blann AD, Amiral J, Mc-Collum CN. Circulating endothelial cell/ leukocyte adhesion molecules in ischaemic heart disease. British J Haem 95: 263-265, 1996.
4. Desideri G, Marinucci MC, Tomassoni G, Masci PG, Santucci A, Ferri C. Vitamin E supplementation reduces plasma VCAM-1 and von Willebrand factor levels and increases nitric oxide concentrations in hypercholesterolemic patients. J Clin Endocrinol Metab 87: 2940-2945, 2002.
5. Fu C, He J, Li C, Shyy JY, Zhu Y. Cholesterol increases adhesion of monocytes to endothelium by moving adhesion molecules out of caveolae. Biochim Biophys Acta 1801: 702-710, 2010.
6. Serrano CV Jr, Pesaro AE, de Lemos JA, et al. Native LDL-C-cholesterol mediated monocyte adhesion molecule overexpression is blocked by simvastatin. Cardiovasc Drugs Ther 23: 215-220, 2009.
7. Cockerill GW, Rye K-A, Gamble JR, Vadas MA, Barter PJ. High-density lipoproteins inhibit cytokine-induced expression of endo-thelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 15: 1987-1994, 1995.
8. Olszewski AJ, Szostak WB, Bialkowska M, Rudnicki S, McCully KS. Reduction of plasma lipid and homocysteine levels by pyri-doxine, folate, cobalamin, choline, riboflavin and troxerutinin in atherosclerosis. Atherosclerosis 75: 1-6, 1989.
9. Lentz SR. Does homocysteine promote atherosclerosis? Arterio-scler Thromb Vasc Biol 21: 1385-1386, 2001.
10. Romano G, Corrado E, Muratori I, et al. Carotid and peripheral atherosclerosis in patients who underwent primary percutaneous coronary intervention and outcome associated with multifocal atherosclerosis. Int Angiol 25: 389-394, 2006.
11. Lundman P, Eriksson MJ, Silveira A, et al. Relation of hypertri-glyceridemia to plasma concentrations of biochemical markers of inflammation and endothelial activation (C-Reactive Protein, Interleukin-6, Soluble Adhesion Molecules, von Willebrand Factor, and Endothelin-1). Am J Cardiol 91: 1128-1130, 2003.
12. Lupattelli G, Lombardini R, Schillaci G, et al. Flow-mediated va-soactivity and circulating adhesion molecules in hypertriglyceride-mia: association with small, dense LDL-C cholesterol particles. Am Heart J 140: 521-526, 2000.
13. Abe Y, El-Masri B, Kimball KT, et al. Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on mono-cyte adhesion. Arterioscler Thromb Vasc Biol 18: 723-731, 1998.
14. Liao D, Tan H, Hui R, et al. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL-C cholesterol clearance. Circ Res 99: 598-606, 2006.
15. Cucuzzela M, Smith P, Nashelsky J. When should we treat isolated high triglycerides? J Fam Pract 53: 142-144, 2004.
16. Assmann G, Schulte H. Results and conclusions of the Prospective Cardiovascular Münster (PROCAM) Study. In: Lipid Metabolism Disorders and Coronary Heart Disease. 21. Assmann G, Ed. MMV Medizin Verlag, 1993: 67.
17. Rubinstein A. National Cholesterol Education Program Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Pan-nel II). Circulation 89: 1333-1445, 1994.
18. LaRosa JC. Cholesterol agonistics. Ann Intern Med 124: 505-508, 1996.
19. Atkins D, DiGuiseppi C. Screening for high blood cholesterol and other lipid abnormalities. In: Guide to Clinical Preventive Services. 2nd ed. Williams & Wilkins, Baltimore, MD, 1996: 15-39.
20. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA 257: 2176-2180, 1987.
21. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure and mortality: Implications from a cohort of 361,662 men. Lancet 2: 933-936, 1986.
22. Allen S, Khan S, Al-Mohanna F, Batten P, Yacoub M. Native low-density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells. J Clin Invest 101: 1064-1075, 1998.
23. Morisaki N, Saito I, Tamura K, et al. New indices of ischemic heart disease and aginig: studies on the serum levels of soluble adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease. Arteriosclerosis 131: 43-48, 1997.
24. Blann AD, Seigneur M, Steiner M, Miller JP, McCollum CN. Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events. Thromb Haemostas 79: 1080-1085, 1998.
25. Kowalski J, Okopien B, Madej A, et al. Levels of sICAM-1, sVCAM-1and MCP-1 in patients with hyperlipoproteinemia IIa and IIb. Int J Clin Pharmacol Ther 39: 48-52, 2001.
26. Hirano K, Ogihara T, Miki M, et al. Homocysteine induces iron-catalyzed lipid peroxidation of low density lipoprotein that is prevented by alpha-tocopherol. Free Rad Res 21: 267-276, 1994.
27. Zhou J, Werstuck GH, Lhotak S, et al. Association of multiple cellular stress pathways with accelerated atherosclerosis in hyper-homocysteinemic apolipoprotein E-deficient mice. Circulation 110: 207-213, 2004.
28. Silverman MD, Tumuluri RJ, Davis M, Lopez G, Rosenbaum JT, Lelkes PI. Homocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion. Arterioscler Thromb Vasc Biol 22: 587, 2002.
29. Araki A, Hosoi T, Orimo H, Ito H. Association of plasma homo-cysteine with serum interleukin-6 and C-peptide levels in patients with type 2 diabetes. Metabolism 54: 809-814, 2005.
30. Suguichi H, Irie T, Uji Y, et al. Homogenous assay for measuring low-density lipoprotein cholesterol in serum with triblock copoly-mer and α-cyclodextrin sulfate. Clin Chem 44: 522-531, 1998.
31. Naito HK. Coronary artery disease and disorders of lipid metabolism. In: Clinical Chemistry. 4th ed. Kaplan L, Pesce AJ, Kaz-mierczak SC, Eds. Mosby, 2003: 603-638.
32. Lindsey CC, Graham MK, Johnston TP, Kiroff CG, Freshley A. A clinical comparison of calculated versus direct measurement of low-density lipoprotein cholesterol level. Pharmacotherapy 24: 167-172, 2004.
33. Rifai N, Ianotti E, deAngelis K, Law T. Analytical and clinical performance of a homogeneous enzymatic LDL-cholesterol assay compared with ultracentrifugation-dextran sulfate-Mg method. Clin Chem 44: 1242-1250, 1998.
34. Dunbar RL, Rader DJ. Demystifying triglycerides: A practical approach for the clinician. Cleve Clin J Med 72: 661-680, 2005.
35. Bartens W, Rader DJ, Talley G, Brewer HB. Decreased plasma levels of lipoprotein(a) in patients with hypertriglyceridemia. Atherosclerosis 108: 149-147, 1994.
36. Werba JP, Safa O, Gianfranceschi G, Michelagnoli S, Sirtori CR, Franceschini G. Plasma triglycerides and lipoprotein(a): inverse relationship in a hyperlipidemic Italian population. Atherosclerosis 101: 203-211, 1993.